Business Overview

Active
Operating Status
Jun 2009
Founded
Hardware, Software
Offering Type
Description
Our mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders at the right place and the right time. MeMeds interdisciplinary team has decades of experience and a proven track record in diverse fields including molecular immunology, informatics, clinical infectious diseases and in vitro diagnostics.
Business Stage
Launched

Founders

Kfir Oved
CTO and CEO
View Email
Eran Eden
CEO

Register for Pro to view

Board Members and Advisors

Paul Feigin
Board Advisor
Itamar Shalit
Board Advisor
Louis Bont
Board Advisor
Israel Potasman
Board Advisor
Zohar Yakhini
Board Advisor
Yoram Reiter
Board Advisor
Modi Segal
Board Advisor
Eli Opper
Board Advisor
Yahal Zilka
Partner, Board Member and Board Advisor
View Email

Investors

Investor

Investor Type

Series Preference

Series C, Series D, Series G
Seed, Series A, Series B, Series C, Series D
Convertible Note, Pre-Seed, Product Crowdfunding, Seed, Series A, Series B, Series C, Series D, Strategic

Funding Rounds

$129,700,000
Total Funding

3

Funding Rounds
Grant
Last Funding Series

Register for Pro to view

Date Announced

Funding Round

Amount Raised

Investors

$2.8 M
Register Pro to View
$70 M
Register Pro to View
$30 M
Register Pro to View

AI Technology Stack™

Certifications and Approvals

Patents

Register for Pro to view

More Startups

STATUS
Acquired
STATUS
Active
STATUS
Active
STATUS
Active
STATUS
Active
FUNDING
$60,300,000
FUNDING STAGE
Series C
STATUS
Active
FUNDING
$600,000
STATUS
Active
STATUS
Active
FUNDING
$11,500,000
FUNDING STAGE
Series A
STATUS
Active
FUNDING
$1,100,000
FUNDING STAGE
Seed
STATUS
Active
FUNDING
$2,300,000
FUNDING STAGE
Series A
STATUS
Active
FUNDING
$7,700,000
FUNDING STAGE
Series A
STATUS
Active
FUNDING
$45,400,000
FUNDING STAGE
Series C
STATUS
Active
STATUS
Active
STATUS
Acquired
FUNDING
$10,000,000
FUNDING STAGE
Series A

Startup Snapshot

Operating Status
Active
Total Funding
$129,700,000
Founded
June 2009
Funding Stage
Grant
Time Since Last Funding Round
2 years

Competitors

Picodya is a startup company developing a revolutionary immunoassay diagnostics platform, capable...
The faster we diagnose, the faster we can treat. At Sight Diagnostics, we aim to improve health t...

Videos

FEATURED VIDEO

Sign up for free

  • Save profiles to your list
  • PDF export of startups and investor profiles
  • Basic search functionality

Fundraising Contact